Endovascular cerebrospinal fluid shunt

Abstract

An endovascular implantable shunt device for draining cerebrospinal fluid from a patient's subarachnoid space includes a shunt having opposed first and second ends, a one-way valve located at the first end of the shunt, a tip disposed at the second end, and a hollow passageway extending between the tip and one-way valve. The tip is constructed to penetrate a patient's sinus wall. Cerebrospinal fluid drains through the tip and out through the valve.

Claims

1. An endovascular implantable shunt device for draining cerebrospinal fluid from a patient's subarachnoid space to the venous system, the device comprising: a shunt having opposed first and second ends; a one-way valve located at the first end of the shunt; a tip disposed at the second end, said tip being constructed to penetrate a sinus wall of the patient; and a hollow passageway extending between the tip and one-way valve such that cerebrospinal fluid can be drained through the tip and out through the valve.

2. The shunt of claim 1, wherein the tip includes a plurality of apertures into which the cerebrospinal fluid enters the tip.

3. The shunt of claim 1, wherein the shunt includes an antithrombic coating.

4. The shunt of claim 1, wherein said tip comprises a closed sharpened end.

5. The shunt of claim 1, wherein said tip is a helical tip and defines a helix having a constant radius.

6. The shunt of claim 1, wherein said first end is tapered.

7. The shunt of claim 1, further comprising a projection between said first and second end, wherein said projection extends along a plane perpendicular to a line extending between said first and second ends of said shunt.

8. The shunt of claim 1, wherein said one-way valve is oriented to block liquid from flowing from said first end toward said second end and to permit liquid to flow from said second end toward said first end.

9. The shunt of claim 1, wherein said one-way valve is configured to be external to the patient's subarachnoid space.

10. A system for draining cerebrospinal fluid from a patient's subarachnoid space to the venous system, the system comprising: an endovascular implantable shunt having opposed first and second ends, a one-way valve located at the first end of the shunt, and a tip disposed at the second end, said tip being constructed to penetrate a sinus wall of the patient, wherein the first and second ends are in fluid communication to enable the cerebrospinal fluid to be drained through the tip and out through the valve; and a catheter for delivering percutaneously and implanting the shunt into the sinus wall.

11. A method for draining cerebrospinal fluid from a patient's subarachnoid space, the method comprising the steps of: providing a shunt having opposed first and second ends, a one-way valve located at the first end of the shunt, and a tip disposed at the second end, said tip being constructed to penetrate a sinus wall of the patient, wherein the first and second ends are in fluid communication to enable the cerebrospinal fluid to be drained through the tip and out through the valve; endovascularly delivering the shunt to the sinus wall; implanting the tip in the sinus wall of the patient; and draining cerebrospinal fluid from the patient.

12. An endovascular implantable shunt device for draining fluid from a patient's subarachnoid space to the venous system, the device comprising: a shunt having opposed first and second ends capable of being deployed by an endovascular route through the venous system, said shunt being sized to pass through a sinus lumen; a one-way valve located between the first end and the second end of the shunt; and a tip disposed at the second end, said tip being constructed to penetrate tissue of the patient; and a hollow passageway extending between the helical tip and one-way valve such that fluid can be drained through the helical tip and out through the valve.

13. The shunt of claim 12, wherein said one-way valve is configured to be external to the patient's subarachnoid space.

14. The shunt of claim 12, wherein said tip comprises a closed sharpened end.

15. The shunt of claim 12, wherein said tip defines a helix having constant radius.

16. The shunt of claim 12, wherein said first end is tapered.

17. The shunt of claim 12, further comprising a projection between said first and second end, wherein said projection extends along a plane perpendicular to a line extending between said first and second ends of said shunt.

18. The shunt of claim 12, wherein said one-way valve is oriented to block liquid from flowing from said first end toward said second end and to permit liquid to flow from said second end toward said first end.

19. The shunt of claim 12, wherein said one-way valve is configured to be external to the patient's subarachnoid space.

20. The shunt of claim 12, further wherein said shunt is sized to pass through a sinus lumen.

Description

BRIEF DESCRIPTION OF THE DRAWINGS

(1) FIG. 1 is a top cross-sectional view of a human skull illustrating the placement of the shunt of the present invention.

(2) FIG. 2 is a partial cross-section of an embodiment of the endovascular shunt of the present invention.

(3) FIG. 3 is a partial view of delivering the endovascular shunt of the present invention to the CSF space of a patient's venous system.

(4) FIG. 4 is a partial view of the implantation of the endovascular shunt of the present invention into the sigmoid sinus wall.

(5) FIG. 5 is a partial view of the endovascular shunt of the present invention implanted in the sigmoid sinus wall.

DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENT

(6) Referring to FIG. 1, the endovascular shunt device of the present invention can be delivered to the right or left sigmoid sinus 12A, 12B of a patient's skull 10 via either the right or left jugular vein respectively of the venous system. The sigmoid sinus lumen 12 is located between the temporal bone (FIGS. 3-5) and the cerebellum.

(7) A shunt 20 is implanted into a sigmoid sinus wall 16, so that one end communicates with CSF located in the cistern or CSF space 18 around the cerebellum 19. The device of the present invention uses the body's natural disease control mechanisms by delivering the CSF from cistern 18 into sigmoid sinus lumen 12 of the venous system. The venous system of the patient can be accesses either through the femoral or jugular veins (not shown) percutaneously. It should be appreciated that the shunt device of the present invention can be delivered to the sigmoid sinus via other locations.

(8) As shown in FIG. 2, one embodiment of the endovascular CSF shunt 20 of the present invention includes opposed first and second ends 22, 24. A one-way valve 26 is located at first end 22. As will be described further herein, CSF can travel through shunt 20 and out end 22, however, other fluid cannot enter the shunt from open end 22.

(9) A helical tip 30 is located at second end 24. As will be described further herein, helical tip 30 has a closed sharpened end 31 that is adapted to penetrate sinus wall 16. Tip 30 includes a plurality of apertures 34 through which the CSF enters the tip. A hollow passageway 32 extends from tip 30 and open end 22, such that the CSF fluid entering through apertures 34 can pass through valve 26 and pass from an outlet 36.

(10) Referring to FIGS. 3-5 and as described above, a delivery catheter 40 is delivered to the venous system via the femoral or jugular vein. Catheter 40 is inserted into sigmoid sinus lumen 12 at a proximal location 13 toward the neck and inserted toward a distal end 15, which is toward the brain.

(11) Delivery catheter 40 includes a second lumen 44 and a shunt delivery port 42. Lumen 44 directs the entire catheter to the correct location with for example, a guide wire, to allow injection of intravenous contrast to visualize the venous lumen. Lumen 44 also supports balloons 46 that can be deployed to occlude venous flow during stunt implantation. Shunt 20 is positioned at an end of an internal catheter 48 that is manipulated through catheter 40 and port 42. To prevent thrombosis within the sigmoid sinus and around the endovascular shunt, shunt 20 can be provided with an antithrombic coating 38

(12) As shown in FIG. 4, internal catheter 48 facilitates twisting of shunt 20 so that it penetrates through sigmoid sinus wall 12. Catheter 48 includes a hollow lumen to allow CSF withdrawal after shunt penetration of the sigmoid sinus wall to confirm that CSF is flowing through the shunt. However, it must be rigid enough to allow twisting of the shunt such that it penetrates the sigmoid sinus wall. Upon insertion, helical tip 30 extends into cistern 18 and CSF located therein. A projection 28 located on shunt 20 between the ends abuts the wall and prevents the shunt from passing therethrough. Upon placement, internal catheter 48 is detached. The CSF can also be aspirated back prior to detachment of catheter 48.

(13) Thereafter, delivery catheter 40 can be removed and shunt 20 is implanted as shown in FIG. 5. CSF 50 draining from outlet 36 from CSF space 18 is delivered to the venous blood flow 17 and removed. It should be appreciated that other means of fluid removal can communicate with shunt 20 to direct the CSF as desired. It also should be appreciated that shunt 20 can incorporate different tips at end 24.

(14) Thus, the endovascular cerebrospinal fluid shunt of the present invention can be placed into a patient percutaneously via a catheter inserted into the venous system of the body through a needle hole, without the need for open surgery and the skin incisions required with current shunt devices. In some patients, the device can be inserted without general anesthesia, which is not possible with current cerebrospinal fluid shunts. The device also will allow for more physiologic drainage of cerebrospinal fluid since the device is shunting cerebrospinal fluid into the same cerebral venous system that occurs naturally in normal people.

(15) Although the present invention has been described in relation to particular embodiments thereof, many other variations and modifications and other uses will become apparent to those skilled in the art. It is preferred therefore, that the present invention be limited not by the specific disclosure herein, but only by the appended claims.